The nucleoprotein (NP) antibody is a class of immunoglobulins specifically targeting the nucleoprotein of influenza viruses. NP is a highly conserved structural protein critical for viral replication, encapsulating viral RNA and facilitating its transcription and replication . Due to its conserved nature across influenza subtypes, NP antibodies are integral to developing broad-spectrum diagnostic tools and vaccines, offering cross-protective immunity against diverse strains .
Role in Virus: NP forms the viral nucleocapsid, stabilizing viral RNA and interacting with polymerase proteins to enable transcription .
Conservation: NP exhibits high sequence homology (>90%) across influenza A and B strains, making it a target for universal diagnostics and therapeutics .
Immune Exposure: Although internal, NP is exposed during viral replication or cell lysis, enabling antibody binding .
NP antibodies contribute to heterosubtypic immunity through mechanisms beyond neutralization:
Complement Activation: Anti-NP IgG triggers complement-mediated lysis of infected cells .
Antibody-Dependent Cellular Cytotoxicity (ADCC): Non-neutralizing antibodies recruit immune effector cells to eliminate infected cells .
T-Cell Modulation: NP antibodies enhance dendritic cell maturation and CD8+ T-cell responses .
NP antibodies are employed in assays for influenza detection:
| Method | Sensitivity | Applications |
|---|---|---|
| Sandwich ELISA | pg/mL | Clinical diagnostics |
| Lateral Flow Assay (LFA) | pg/mL | Rapid point-of-care testing |
| Single Radial Immunodiffusion (SRD) | μg/mL | Serologic surveys |
Broad Protection: Monoclonal anti-NP antibodies (e.g., HB65) reduce viral titers and morbidity in animal models .
Cross-Strain Efficacy: NP-targeting antibodies protect against heterologous influenza strains (e.g., H1N1, H3N2) .
Non-Influenza Viruses: NP antibodies have shown efficacy against Crimean-Congo Hemorrhagic Fever Virus (CCHFV) .